Medikaloka Hermina Tbk PT
IDX:HEAL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 070
1 595
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Medikaloka Hermina Tbk PT
Medikaloka Hermina Tbk PT
Net Income (Common)
Medikaloka Hermina Tbk PT
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medikaloka Hermina Tbk PT
IDX:HEAL
|
Net Income (Common)
Rp556.7B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Siloam International Hospitals Tbk PT
IDX:SILO
|
Net Income (Common)
Rp987.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
77%
|
CAGR 10-Years
28%
|
|
|
Metro Healthcare Indonesia Tbk PT
IDX:CARE
|
Net Income (Common)
-Rp110.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
Net Income (Common)
Rp9.4B
|
CAGR 3-Years
-67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mitra Keluarga Karyasehat Tbk PT
IDX:MIKA
|
Net Income (Common)
Rp1.1T
|
CAGR 3-Years
-3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
F
|
Famon Awal Bros Sedaya Tbk PT
IDX:PRAY
|
Net Income (Common)
Rp217B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medikaloka Hermina Tbk PT
Glance View
Medikaloka Hermina Tbk PT, commonly known as Hermina, has carved a significant niche in Indonesia's healthcare sector, evolving from its humble beginnings into a formidable operator of private hospitals. Founded in 1985, Hermina began as a maternity hospital in Jakarta, and over the decades, it deftly expanded its network to become the largest private hospital operator in the country by bed capacity. Central to Hermina’s growth strategy has been its focus on providing comprehensive women's and children's healthcare services, all while scaling up to offer general medical services, which attract a diverse patient demographic. The company's growth is underscored by its strategic location choices, placing hospitals in areas with significant population density, thus ensuring a steady influx of patients. Hermina generates revenue by offering a wide range of services, from inpatient and outpatient care to specialized medical treatments and surgeries. A significant portion of their income is driven by the robust maternity and pediatric services, which holds a strong customer loyalty due to decades of trusted service. Furthermore, Hermina has successfully navigated the complexities of Indonesia's healthcare insurance landscape, integrating both public health insurance plans and private offerings, widening their accessibility and market reach. This balanced approach helps sustain their profit margins in a competitive environment where healthcare access is rapidly evolving. Their commitment to expanding service offerings and maintaining high standards of medical care while adapting to digital health trends continues to position them as a leader in the Indonesian healthcare market.
See Also
What is Medikaloka Hermina Tbk PT's Net Income (Common)?
Net Income (Common)
556.7B
IDR
Based on the financial report for Sep 30, 2024, Medikaloka Hermina Tbk PT's Net Income (Common) amounts to 556.7B IDR.
What is Medikaloka Hermina Tbk PT's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
20%
Over the last year, the Net Income (Common) growth was 39%. The average annual Net Income (Common) growth rates for Medikaloka Hermina Tbk PT have been -17% over the past three years , 20% over the past five years .
You don't have any saved screeners yet